Phase II Study of Cholesterol- and Cholestanol-Free Diet, Lovastatin, and Chenodeoxycholic Acid for Cerebrotendinous Xanthomatosis

NCT00004346 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

5

Enrollment

NIH

Sponsor class

Conditions

Cerebrotendinous Xanthomatosis

Interventions

DRUG: chenodeoxycholic acid
DRUG: lovastatin

Sponsor

National Center for Research Resources (NCRR)

Collaborators

[object Object]